To compare the effects of rosuvastatin to protease inhibitor switching on:~Total cholesterol through week 12~Safety parameters (HIV viral load, clinical adverse events, serious adverse events, laboratory adverse events, modifications to antiretroviral therapy)~Quality of life (SF-12)~Fasting LDL cholesterol (estimated with Friedewald equation unless triglycerides >400mg/dL, in which case LDL-C would be measured directly), HDL cholesterol, total : HDL cholesterol ratio, LDL particles sizes, triglycerides~Fasting glucose and insulin~Framingham cardiovascular risk score~D:A:D 5-year estimated risk calculator
To compare the effect of rosuvastatin to protease inhibitor switching on fasting total cholesterol over 12 weeks.